Skip to main content
Top

Diabetes Therapy

Issue 8/2020

Content (24 Articles)

Open Access Insulins Review

Treatment Options for MODY Patients: A Systematic Review of Literature

Maurizio Delvecchio, Carmela Pastore, Paola Giordano

Open Access Neuropathic Pain Original Research

The Effectiveness of Acceptance and Commitment Therapy on Pain Acceptance and Pain Perception in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial

Amir Abbas Taheri, Ali Akbar Foroughi, Youkhabeh Mohammadian, Seyed Mojtaba Ahmadi, Khatereh Heshmati, Leila Afshar Hezarkhani, Ali Akbar Parvizifard

Open Access Pharmacokinetics Original Research

Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects

Helle Linnebjerg, Elizabeth Smith LaBell, Mary Anne Dellva, David E. Coutant, Jennifer Leohr

Open Access Linagliptin Original Research

Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial

Hirotaka Watada, Hiroyuki Sakamaki, Daisuke Yabe, Fumiko Yamamoto, Tatsunori Murata, Keigo Hanada, Tetsuaki Hirase, Tomoo Okamura

Open Access Insulins Original Research

Key Strategies for Overcoming Psychological Insulin Resistance in Adults with Type 2 Diabetes: The UK Subgroup in the EMOTION Study

Elemer G. Balogh, Magaly Perez-Nieves, Dachuang Cao, Irene I. Hadjiyianni, Nadeem Ashraf, Urvi Desai, Frank J. Snoek, Jackie A. Sturt

Open Access Insulins Original Research

Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden

Björn Eliasson, Jan Ekelund, Mervete Miftaraj, Mattis Flyvholm Ranthe, Ann-Charlotte Mårdby, João Diogo Da Rocha Fernandes, Ann-Marie Svensson

Open Access Insulin Glargine Original Research

Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study

Ides M. Colin, Kathy Alexandre, Jacques Bruhwyler, André Scheen, Ann Verhaegen

Open Access Glimepiride Original Research

Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials

Silvina Gallo, Roberto A. Calle, Steven G. Terra, Annpey Pong, Lisa Tarasenko, Annaswamy Raji

Insulin Glargine Original Research

Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes

Ronan Roussel, Bruno Detournay, Zahra Boultif, Amar Bahloul, Clement Teissier, Bernard Charbonnel

Open Access Hypoglycemia Brief Report

Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study

Keisuke Ueno, Daisuke Chujo, Nobuyuki Takahashi, Mitsuru Ohsugi, Kohjiro Ueki, Hiroshi Kajio

Glimepiride Study Protocol

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Ryoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, Tomoaki Tatsumi, Sho Takahashi, Kengo Nagashima, Noriko Asaumi, Miyuki Arai, Fumio Shimada, Kaori Tachibana, Yoshihiro Watanabe, Ko Ishikawa, Akiko Hoshino, Kyohei Yamamoto, Mariko Kubota-Taniai, Takafumi Mayama, Shuichi Yamamoto, Koutaro Yokote

Open Access Insulins Correction

Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design

Tadej Battelino, Zsolt Bosnyak, Thomas Danne, Bhaswati Mukherjee, Steve Edelman, Valerie Pilorget, Pratik Choudhary, Eric Renard, Richard Bergenstal

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.